PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
40.25%
Net income growth 1.25-1.5x MCHP's 27.01%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
-0.97%
Both reduce yoy D&A, with MCHP at -4.68%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-54.05%
Negative yoy deferred tax while MCHP stands at 24.08%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-1.28%
Negative yoy SBC while MCHP is 18.52%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
34.11%
Slight usage while MCHP is negative at -218.86%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-10.74%
AR is negative yoy while MCHP is 171.85%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-276.47%
Both reduce yoy inventory, with MCHP at -30.01%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
49.57%
A yoy AP increase while MCHP is negative at -251.32%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
99.28%
Some yoy usage while MCHP is negative at -75.06%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
81.82%
Some yoy increase while MCHP is negative at -67.81%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
67.75%
Some CFO growth while MCHP is negative at -5.78%. John Neff would note a short-term liquidity lead over the competitor.
-3.90%
Negative yoy CapEx while MCHP is 1.11%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
60.51%
Purchases well above MCHP's 11.35%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
64.84%
Proceeds from sales/maturities above 1.5x MCHP's 3.05%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-302.63%
Both yoy lines negative, with MCHP at -118.51%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
362.95%
Investing outflow well above MCHP's 16.67%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-100.80%
Both yoy lines negative, with MCHP at -197.35%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
-55.83%
Both yoy lines negative, with MCHP at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-3.19%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.